CROFT MEDICAL CENTRE — All Prescriptions & Medications — Page 8
Practice Code: M84015 | LEAMINGTON SPA, CV31 1SA
Showing results 351-400 of 664
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ondansetron hydrochloride | 64 | 4,318 | £1.8K | +31.9% ▲ |
| Sennosides | 63 | 27.8K | £560 | +104.0% ▲ |
| Dexamfetamine sulfate | 63 | 4,060 | £4.5K | +75.2% ▲ |
| Azithromycin | 63 | 1,092 | £237 | -50.3% ▼ |
| Zuclopenthixol decanoate | 62 | 164 | £1.1K | +286.1% ▲ |
| Risedronate sodium | 61 | 460 | £169 | -49.7% ▼ |
| Goserelin acetate | 61 | 61 | £11.2K | +38.5% ▲ |
| Other individually formulated bought in preparations | 61 | 2,867 | £841 | +86.7% ▲ |
| 61 | 799 | £1.8K | +192.1% ▲ | |
| Chlortalidone | 60 | 2,774 | £5.1K | +508.3% ▲ |
| Glycopyrronium bromide | 60 | 2,490 | £2.1K | +61.0% ▲ |
| Cinnarizine | 60 | 5,602 | £261 | +28.2% ▲ |
| Irbesartan | 57 | 3,289 | £241 | -76.6% ▼ |
| Powder amino acid formula (0913107) | 57 | 148.8K | £9.4K | +72.6% ▲ |
| 57 | 1,540 | £523 | +44.6% ▲ | |
| Rivastigmine | 56 | 2,186 | £1.9K | -18.6% ▼ |
| Co-trimoxazole(Trimethoprim/sulfamethoxazole) | 55 | 4,346 | £463 | +36.9% ▲ |
| Zolmitriptan | 54 | 774 | £2.5K | -16.8% ▼ |
| Tamsulosin and dutasteride hydrochloride | 54 | 2,700 | £1,000 | +54.5% ▲ |
| Ipratropium bromide | 54 | 57 | £412 | +233.0% ▲ |
| Bezafibrate | 53 | 2,674 | £538 | -1.6% vs avg |
| Celecoxib | 53 | 3,560 | £210 | -19.7% ▼ |
| 53 | 430 | £161 | +83.0% ▲ | |
| Sodium picosulfate | 52 | 18.0K | £1.6K | +43.3% ▲ |
| Pericyazine | 52 | 1,456 | £1.5K | -52.9% ▼ |
| Medroxyprogesterone acetate | 52 | 2,613 | £512 | +35.9% ▲ |
| Leuprorelin acetate | 52 | 52 | £6.2K | +12.2% ▲ |
| Benzydamine hydrochloride | 51 | 13.4K | £265 | -34.1% ▼ |
| Ciclosporin (Eye Anti Inflammatory) | 50 | 2,760 | £6.6K | +101.6% ▲ |
| 50 | 977 | £2.2K | +34.7% ▲ | |
| Tiotropium bromide/olodaterol | 49 | 57 | £1.8K | -20.1% ▼ |
| Nefopam hydrochloride | 49 | 5,178 | £221 | -56.7% ▼ |
| Sodium chloride | 49 | 2,908 | £1.8K | +64.7% ▲ |
| Lurasidone | 48 | 2,688 | £7.3K | +92.4% ▲ |
| Erythromycin ethylsuccinate | 48 | 6,396 | £591 | +105.6% ▲ |
| 48 | 3,400 | £904 | +63.3% ▲ | |
| Flupentixol decanoate | 47 | 81 | £973 | +194.5% ▲ |
| Quinine bisulfate | 47 | 2,128 | £420 | +21.1% ▲ |
| Meloxicam | 47 | 1,872 | £61 | -28.9% ▼ |
| 47 | 1,740 | £3.1K | +216.5% ▲ | |
| Bempedoic acid/Ezetimibe | 46 | 2,324 | £4.4K | -24.7% ▼ |
| Tacrolimus | 46 | 2,310 | £1.7K | -14.7% ▼ |
| Procyclidine hydrochloride | 45 | 3,676 | £169 | -68.2% ▼ |
| 45 | 1,500 | £980 | +72.7% ▲ | |
| Pramipexole | 44 | 3,900 | £698 | -55.2% ▼ |
| Azelastine hydrochloride | 44 | 1,144 | £513 | +292.6% ▲ |
| Co-beneldopa (Benserazide/levodopa) | 43 | 7,800 | £592 | -71.6% ▼ |
| 43 | 1,570 | £369 | -0.3% vs avg | |
| Oxytetracycline | 42 | 4,790 | £1.8K | +62.6% ▲ |
| Alfuzosin hydrochloride | 42 | 1,806 | £575 | -41.3% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.